1. Tao, Mingyue, Luo, Jing, Gu, Tong, Luo, Chao, Wang, Qilong. 2021. LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma. In Cell death & disease, 12, 845. doi:10.1038/s41419-021-04132-6. https://pubmed.ncbi.nlm.nih.gov/34518524/
2. Wei, Chunhua, Dong, Xiaomin, Lu, Hui, Wu, Gang, Dong, Xiaorong. 2019. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. In Journal of experimental & clinical cancer research : CR, 38, 95. doi:10.1186/s13046-019-1092-4. https://pubmed.ncbi.nlm.nih.gov/30791942/
3. He, Rong-Quan, Li, Jian-Di, Du, Xiu-Fang, Yang, Hong, Chen, Gang. 2021. LPCAT1 overexpression promotes the progression of hepatocellular carcinoma. In Cancer cell international, 21, 442. doi:10.1186/s12935-021-02130-4. https://pubmed.ncbi.nlm.nih.gov/34419067/
4. Liu, Ran, Yin, Chuanzheng, Zhao, Peng, Liu, Gang Logan, Song, Zifang. 2023. Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis. In Biology direct, 18, 67. doi:10.1186/s13062-023-00428-z. https://pubmed.ncbi.nlm.nih.gov/37875967/
5. Ji, Weidan, Peng, Zhangxiao, Sun, Bin, Guo, Minggao, Su, Changqing. 2021. LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1. In Frontiers in oncology, 11, 678714. doi:10.3389/fonc.2021.678714. https://pubmed.ncbi.nlm.nih.gov/34178664/
6. Takahashi, Tsukasa, Fee, Erin L, Takahashi, Yuki, Choolani, Mahesh A, Kemp, Matthew W. 2023. LPCAT1 levels in the placenta, the maternal plasma and the fetal plasma do not predict fetal lung responses to glucocorticoids in a sheep model of pregnancy. In Placenta, 138, 1-9. doi:10.1016/j.placenta.2023.04.012. https://pubmed.ncbi.nlm.nih.gov/37146534/